Nab-paclitaxel is effective against intrahepatic cholangiocarcinoma via disruption of desmoplastic stroma. [electronic resource]
Publication details: Oncology letters Jul 2018Description: 566-572 p. digitalISSN:- 1792-1074
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.